International Association for the Study of Lung Cancer ( IASLC)

Primary tabs

IASLC's picture

Management

Contact Address

About International Association for the Study of Lung Cancer

The International Association for the Study of Lung Cancer (IASLC) is the only global organization dedicated to the study of lung cancer. Founded in 1974, the association's membership includes more than 4,000 lung cancer specialists in over 90 countries.

IASLC press release, blog etc

Tue, 12/16/2025 - 21:45 Global Lung Cancer Experts Selected to Lead IASLCs 2027 World Conference
Fri, 10/10/2025 - 05:57 IASLC and Pfizer Announce HOPE Project Grant Recipients to Advance Lung Cancer Care in China
Tue, 09/09/2025 - 20:06 Lung Cancer Europe Study Highlights Communication Gaps and Need for Shared Decision-Making
Tue, 09/09/2025 - 20:01 PALOMA-2 Study: Subcutaneous Amivantamab Every 4 Weeks Plus Lazertinib Shows High Response Rate in EGFR-Mutated NSCLC
Tue, 09/09/2025 - 19:59 FANSS Study Demonstrates Feasibility of U.S.-Based Lung Cancer Screening in Asian Female Nonsmokers
Tue, 09/09/2025 - 19:58 Novel Immunotherapy Strategy Shows Promising Long-Term Survival in Advanced NSCLC Patients with Inadequate Response to Immune Checkpoint Inhibitors
Tue, 09/09/2025 - 19:53 Surgery After EGFR TKI Shows Promise in Prolonging Progression-Free Survival in Metastatic NSCLC
Tue, 09/09/2025 - 19:53 Circulating Tumor DNA May Guide Immunotherapy Use in Limited-Stage SCLC, New Study Shows
Mon, 09/08/2025 - 19:31 Tarlatamab with Anti-PD-L1 as First-Line Maintenance After Chemo-Immunotherapy for ES-SCLC Demonstrates Acceptable Safety Profile and Unprecedented Overall Survival
Mon, 09/08/2025 - 07:56 EA5181 Phase 3 Trial Finds No OS Benefit for Concurrent and Consolidative Durvalumab vs Consolidation Alone in Unresectable Stage 3 NSCLC
Mon, 09/08/2025 - 07:55 Lung Cancer Screening Benefits Adults Up to Age 80 if Surgical Candidates, UK Study Finds
Mon, 09/08/2025 - 07:53 Video Assisted Thoracoscopy Surgery Reduces Mortality by 21 Percent Compared to Lobectomy
Mon, 09/08/2025 - 07:51 Spread Through Airspaces (STAS) Associated with Poor Prognosis in Early-Stage NSCLC Across Lobectomy and Segmentectomy Procedures
Mon, 09/08/2025 - 07:49 Phase III Trial Finds Hypofractionated Radiotherapy with Chemotherapy Offers Comparable Survival and Lower Toxicity to Conventional Schedule in LS-SCLC
Mon, 09/08/2025 - 07:48 NADIM ADJUVANT Trial Suggests Benefit of Adjuvant Chemo-Immunotherapy in Resected Stage IBIIIA NSCLC
Mon, 09/08/2025 - 07:45 BMS-986504 Demonstrates Durable Responses in MTAP-Deleted NSCLC, Including EGFR and ALK-Positive Tumors
Sun, 09/07/2025 - 12:40 FLAURA2 Trial Shows Osimertinib Plus Chemotherapy Improves Overall Survival in EGFR-Mutated Advanced NSCLC
Sun, 09/07/2025 - 12:40 First-in-Human Trial Shows Promising Results for DLL3-Targeted Antibody-Drug Conjugate SHR-4849 in Relapsed Small Cell Lung Cancer
more

InfoBox

HomePagewww.iaslc.org